FDA grants fast track status to Moderna’s mRNA therapeutic to treat propionic acidemia

FDA grants fast track status to Moderna’s mRNA therapeutic to treat propionic acidemia

Submitted by admin on October 23, 2019 - 9:29am
Source: 
Pharmaceutical Business Review
News Tags: 
Moderna Therapeutics
mRNA-3927
propionic acidemia
fast track
FDA
Headline: 
FDA grants fast track status to Moderna’s mRNA therapeutic to treat propionic acidemia
snippet: 

Moderna has designed mRNA-3927 to instruct the body to restore the missing or dysfunctional proteins, which cause PA. PA is a rare, life-threatening and inherited a metabolic disorder

Do Not Allow Advertisers to Use My Personal information